Heilongjiang ZBD Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Heilongjiang ZBD Pharmaceutical has a total shareholder equity of CN¥8.4B and total debt of CN¥3.5B, which brings its debt-to-equity ratio to 41.2%. Its total assets and total liabilities are CN¥13.0B and CN¥4.6B respectively. Heilongjiang ZBD Pharmaceutical's EBIT is CN¥812.3M making its interest coverage ratio -3.6. It has cash and short-term investments of CN¥1.2B.
Key information
41.2%
Debt to equity ratio
CN¥3.48b
Debt
| Interest coverage ratio | -3.6x |
| Cash | CN¥1.22b |
| Equity | CN¥8.44b |
| Total liabilities | CN¥4.60b |
| Total assets | CN¥13.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603567's short term assets (CN¥7.9B) exceed its short term liabilities (CN¥3.1B).
Long Term Liabilities: 603567's short term assets (CN¥7.9B) exceed its long term liabilities (CN¥1.5B).
Debt to Equity History and Analysis
Debt Level: 603567's net debt to equity ratio (26.7%) is considered satisfactory.
Reducing Debt: 603567's debt to equity ratio has reduced from 43.8% to 41.2% over the past 5 years.
Debt Coverage: 603567's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603567 earns more interest than it pays, so coverage of interest payments is not a concern.